Q2 2018 Holdings
Filed 2018-08-14 | 15 holdings | $414.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Deciphera Pharmaceuticals Inc(DCPHEUR) | COM | 24344T101 | $161.5K | 4,104,140 | 39.0% |
| Aptinyx Inc | COM | 03836N103 | $79.5K | 3,290,079 | 19.2% |
| Neuronetics Inc(STIM) | COM | 64131A105 | $41.1K | 1,543,115 | 9.9% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $26.1K | 444,708 | 6.3% |
| Unum Therapeutics Inc | COM | 903214104 | $25.8K | 1,795,545 | 6.2% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $16.6K | 433,429 | 4.0% |
| Iterum Therapeutics PLC | SHS | G6333L101 | $15.5K | 1,456,303 | 3.8% |
| Sierra Oncology Inc | COM | 82640U107 | $14.9K | 5,020,446 | 3.6% |
| Obseva SA | COM | H5861P103 | $13.5K | 890,501 | 3.3% |
| Versartis Inc | COM | 92529L102 | $4.6K | 2,247,000 | 1.1% |
| Avrobio Inc | COM | 05455M100 | $4.3K | 150,000 | 1.0% |
| Oxford Immunotec Global PLC | ORD SHS | G6855A103 | $4.0K | 311,660 | 1.0% |
| Affimed N V | COM | N01045108 | $3.7K | 2,250,000 | 0.9% |
| Edge Therapeutics Inc | COM | 279870109 | $2.4K | 2,344,868 | 0.6% |
| Aveo Pharmaceuticals Inc(AVEOEUR) | COM | 053588109 | $909 | 402,118 | 0.2% |